CRPG.F logo

China Resources Pharmaceutical Group OTCPK:CRPG.F Stock Report

Last Price

US$0.56

Market Cap

US$3.7b

7D

0%

1Y

n/a

Updated

24 Jan, 2024

Data

Company Financials +

China Resources Pharmaceutical Group Limited

OTCPK:CRPG.F Stock Report

Market Cap: US$3.7b

CRPG.F Stock Overview

An investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. More details

CRPG.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance2/6
Financial Health3/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

China Resources Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for China Resources Pharmaceutical Group
Historical stock prices
Current Share PriceHK$0.56
52 Week HighHK$0.56
52 Week LowHK$0.56
Beta0.38
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

CRPG.FUS PharmaceuticalsUS Market
7D0%-0.3%-2.7%
1Yn/a7.9%23.4%

Return vs Industry: Insufficient data to determine how CRPG.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CRPG.F performed against the US Market.

Price Volatility

Is CRPG.F's price volatile compared to industry and market?
CRPG.F volatility
CRPG.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement10.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: CRPG.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CRPG.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200771,000Xiaosong Baiwww.crpharm.com

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.

China Resources Pharmaceutical Group Limited Fundamentals Summary

How do China Resources Pharmaceutical Group's earnings and revenue compare to its market cap?
CRPG.F fundamental statistics
Market capUS$3.70b
Earnings (TTM)US$531.89m
Revenue (TTM)US$34.18b

7.0x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRPG.F income statement (TTM)
RevenueHK$267.33b
Cost of RevenueHK$225.69b
Gross ProfitHK$41.64b
Other ExpensesHK$37.48b
EarningsHK$4.16b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.66
Gross Margin15.58%
Net Profit Margin1.56%
Debt/Equity Ratio81.3%

How did CRPG.F perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/24 12:33
End of Day Share Price 2023/10/27 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Resources Pharmaceutical Group Limited is covered by 20 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Shun Kei LawCCB International Securities Limited
Zhishun SiuCCB International Securities Limited